(MedPage Today) — ORLANDO — Novel interleukin (IL)-2 receptor agonist and regulatory T-cell (Treg) proliferator rezpegaldesleukin improved control of atopic dermatitis with potential incidental benefit for comorbid asthma as well, the phase…
Source link : https://www.medpagetoday.com/meetingcoverage/acaai/118419
Author :
Publish date : 2025-11-10 18:14:00
Copyright for syndicated content belongs to the linked Source.











